Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Pfizer buys Biohaven’s migraine drugs for $11.6 billion.

< BACK TO ARCHIVE


Papers: 21 May 2022 - 27 May 2022


2022 May 20


Nat Rev Drug Discov


http://www.ncbi.nlm.nih.gov/pubmed/35596076?dopt=Abstract

Pfizer buys Biohaven’s migraine drugs for $11.6 billion.

Authors

Pfizer buys Biohaven's migraine drugs for $11.6 billion.
Kingwell K
Nat Rev Drug Discov. 2022 May 20.
PMID: 35596076.
Read This Paper